S. W. MAY

424 total citations
22 papers, 321 citations indexed

About

S. W. MAY is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, S. W. MAY has authored 22 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Physiology. Recurrent topics in S. W. MAY's work include Enzyme function and inhibition (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Pain Mechanisms and Treatments (2 papers). S. W. MAY is often cited by papers focused on Enzyme function and inhibition (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Pain Mechanisms and Treatments (2 papers). S. W. MAY collaborates with scholars based in United States. S. W. MAY's co-authors include P.W. Mueller, Robert S. Phillips, Stanley H. Pollock, Kandatege Wimalasena, E. T. Kaiser, Lee Barrett, Alfred Moore, Judith Crockett, Gerald S. Pullman and Xianyuan Zeng and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

S. W. MAY

22 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. W. MAY United States 11 178 60 55 48 46 22 321
Herbert J. Sipe United States 10 137 0.8× 44 0.7× 40 0.7× 127 2.6× 29 0.6× 16 385
Yuchiong Hsuanyu Canada 10 185 1.0× 45 0.8× 19 0.3× 52 1.1× 51 1.1× 19 469
Yasuko Kawamura‐Konishi Japan 13 236 1.3× 31 0.5× 101 1.8× 29 0.6× 65 1.4× 30 505
Kazuyoshi Fujitani Japan 12 157 0.9× 15 0.3× 22 0.4× 150 3.1× 67 1.5× 40 441
Allan L. Wilcox United States 9 139 0.8× 20 0.3× 29 0.5× 158 3.3× 29 0.6× 13 397
W D Hewson Canada 9 153 0.9× 105 1.8× 9 0.2× 69 1.4× 123 2.7× 12 452
E. Ann Hallinan United States 15 224 1.3× 48 0.8× 15 0.3× 433 9.0× 41 0.9× 20 717
G. Milazzo 2 196 1.1× 26 0.4× 14 0.3× 25 0.5× 32 0.7× 2 329
Stephanie Whitman United States 11 243 1.4× 13 0.2× 16 0.3× 164 3.4× 44 1.0× 12 532
Hiroyuki Nakahira Japan 13 150 0.8× 27 0.5× 12 0.2× 329 6.9× 44 1.0× 25 500

Countries citing papers authored by S. W. MAY

Since Specialization
Citations

This map shows the geographic impact of S. W. MAY's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. W. MAY with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. W. MAY more than expected).

Fields of papers citing papers by S. W. MAY

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. W. MAY. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. W. MAY. The network helps show where S. W. MAY may publish in the future.

Co-authorship network of co-authors of S. W. MAY

This figure shows the co-authorship network connecting the top 25 collaborators of S. W. MAY. A scholar is included among the top collaborators of S. W. MAY based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. W. MAY. S. W. MAY is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MAY, S. W., et al.. (2020). Characterization of a novel enzyme from Photobacterium phosphoreum with histidine decarboxylase activity. International Journal of Food Microbiology. 334. 108815–108815. 13 indexed citations
2.
Pullman, Gerald S., et al.. (2015). Conifer somatic embryogenesis: improvements by supplementation of medium with oxidation-reduction agents. Tree Physiology. 35(2). 209–224. 33 indexed citations
3.
Ensley, A., et al.. (2001). Evaluation of Cardiovascular Parameters of a Selenium-Based Antihypertensive Using Pulsed Doppler Ultrasound. Journal of Cardiovascular Pharmacology. 38(3). 337–346. 9 indexed citations
4.
Cutler, Stephen J., et al.. (1998). Pharmacological evaluation of 1-(carboxymethyl)-3,5-diphenyl-2-methylbenzene, a novel arylacetic acid with potential anti-inflammatory properties. Inflammation Research. 47(7). 316–324. 8 indexed citations
5.
MAY, S. W., et al.. (1997). Antiinflammatory and Analgesic Activity of an Inhibitor of Neuropeptide Amidation. Journal of Pharmacology and Experimental Therapeutics. 280(2). 846–853. 37 indexed citations
6.
Sirimanne, Sarath R. & S. W. MAY. (1995). Interaction of non-conjugated olefinic substrate analogues with dopamine β-monooxygenase: catalysis and mechanism-based inhibition. Biochemical Journal. 306(1). 77–85. 4 indexed citations
7.
MAY, S. W., et al.. (1994). NN-dimethyl-1,4-phenylenediamine as an alternative reductant for peptidylglycine α-amidating mono-oxygenase catalysis. Biochemical Journal. 300(1). 31–36. 14 indexed citations
8.
Pollock, Stanley H., et al.. (1993). The oral antihypertensive activity of the methylated derivatives of phenyl-2-aminoethyl sulfide.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1113–1117. 3 indexed citations
9.
Wimalasena, Kandatege, et al.. (1989). Effects of dopamine β-monooxygenase substrate analogs on ascorbate levels and norepinephrine synthesis in adrenal chromaffin granule ghosts. Journal of Biological Chemistry. 264(1). 124–130. 12 indexed citations
10.
Pollock, Stanley H., et al.. (1988). Demonstration of the antihypertensive activity of phenyl-2-aminoethyl selenide.. Journal of Pharmacology and Experimental Therapeutics. 246(1). 227–234. 17 indexed citations
12.
Wimalasena, Kandatege, et al.. (1988). Demonstration of the ascorbate dependence of membrane-bound dopamine beta-monooxygenase in adrenal chromaffin granule ghosts.. Journal of Biological Chemistry. 263(2). 666–672. 27 indexed citations
13.
Sirimanne, Sarath R., et al.. (1987). Interaction of dopamine β-mono-oxygenase with substituted imidazoles and pyrazoles. Catalysis and inhibition. Biochemical Journal. 242(1). 227–233. 5 indexed citations
14.
Padgette, Stephen R., et al.. (1985). ChemInform Abstract: ANTIHYPERTENSIVE ACTIVITIES OF PHENYL AMINOETHYL SULFIDES, A CLASS OF SYNTHETIC SUBSTRATES FOR DOPAMINE β‐HYDROXYLASE. Chemischer Informationsdienst. 16(9). 2 indexed citations
16.
Felton, Ronald H., et al.. (1982). EXAFS and Raman evidence for histidine binding at the active site of protocatechuate 3,4-dioxygenase. Journal of the American Chemical Society. 104(22). 6132–6134. 28 indexed citations
17.
MAY, S. W., et al.. (1981). Dopamine beta-hydroxylase. Comparative specificities and mechanisms of the oxygenation reactions.. Journal of Biological Chemistry. 256(16). 8470–8475. 39 indexed citations
18.
MAY, S. W., et al.. (1981). Dopamine beta-hydroxylase. Demonstration of enzymatic ketonization of the product enantiomer S-octopamine.. Journal of Biological Chemistry. 256(5). 2258–2261. 29 indexed citations
19.
MAY, S. W. & E. T. Kaiser. (1971). pH dependence of the pepsin-catalyzed hydrolysis of bis-p-nitrophenyl sulfite. Journal of the American Chemical Society. 93(21). 5567–5572. 5 indexed citations
20.
MAY, S. W. & E. T. Kaiser. (1969). Pepsin-catalyzed hydrolysis of bis-p-nitrophenyl sulfite and its inhibition by diphenyl sulfite at pH 2. Journal of the American Chemical Society. 91(23). 6491–6495. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026